Literature DB >> 25022707

Transarterial degradation of hyaluronic acid filler by hyaluronidase.

Claudio DeLorenzi1.   

Abstract

BACKGROUND: Hyaluronidase (HYAL) has been recommended in the emergency treatment of ischemia caused by accidental intra-arterial injection of hyaluronic acid (HA) dermal fillers. To date, there have been no published studies showing that HYAL can pass through intact arterial wall to hydrolyze HA emboli.
OBJECTIVE: The goal of this study was to study whether or not HYAL could cross intact human facial arterial wall to hydrolyze HA filler.
MATERIALS AND METHODS: Short tied-off segments of fresh human cadaver-sourced facial artery specimens, overfilled with a monophasic dermal filler (dermal filler "sausages"), were immersed in either HYAL or normal saline as controls. At 4 and 24 hours, the vessels were removed from the preparations, and one end of each vessel was cut open.
RESULTS: Only the HYAL-immersed specimens showed degradation of filler gel.
CONCLUSION: In conclusion, cross-linked HA is susceptible to hydrolysis by HYAL when contained within the intact facial artery in a cadaver model, indicating that direct intra-arterial injection of HYAL is likely not necessary to help restore the circulation of ischemic tissues. This bench study provides support for the current recommended treatment of accidental intra-arterial injection with HYAL injection diffusely into ischemic tissues.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25022707     DOI: 10.1097/DSS.0000000000000062

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  13 in total

1.  This month's guideline: The Use of Hyaluronidase in Aesthetic Practice (v2.4).

Authors:  Martyn King; Cormac Convery; Emma Davies
Journal:  J Clin Aesthet Dermatol       Date:  2018-06-01

2.  Doppler Ultrasound in the Management of Vascular Complications Associated with Hyaluronic Acid Dermal Fillers.

Authors:  Marco Antonio Munia; Christine Guarnieri Munia; Meire Brasil Parada; Jose Ben-Hurferraz Parente; Nelson Wolosker
Journal:  J Clin Aesthet Dermatol       Date:  2022-02

3.  Effectiveness of Low Doses of Hyaluronidase to Remove Hyaluronic Acid Filler Nodules: A Randomized Clinical Trial.

Authors:  Murad Alam; Rosemara Hughart; Amelia Geisler; Kapila Paghdal; Amanda Maisel; Alexandra Weil; Dennis P West; Emir Veledar; Emily Poon
Journal:  JAMA Dermatol       Date:  2018-07-01       Impact factor: 10.282

4.  Non-surgical Rhinoplasty and Use of Hyaluronic Acid Based Dermal Filler-User Experience in Few Subjects.

Authors:  Brajendra Baser; Pallavi Singh; Pragati Shubha; Pronab Kumar Roy; Priya Chaubey
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-09-03

Review 5.  Treatment Algorithm for Hyaluronic Acid-Related Complication Based on a Systematic Review of Case Reports, Case Series, and Clinical Experience.

Authors:  Uri Aviv; Josef Haik; Nathaniel Weiss; Ariel Berl; Hagit Ofir; Gil Nardini; Michelle Cleary; Rachel Kornhaber; Moti Harats
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2020-09-01

6.  Periorbital Injectables: Understanding and Avoiding Complications.

Authors:  Catherine J Hwang
Journal:  J Cutan Aesthet Surg       Date:  2016 Apr-Jun

7.  Hyaluronidase: An overview of its properties, applications, and side effects.

Authors:  Hyunwook Jung
Journal:  Arch Plast Surg       Date:  2020-07-15

8.  Early hyaluronidase use in preventing skin necrosis after treatment with dermal fillers: Report of two cases.

Authors:  Francesco Ciancio; Maria Stella Tarico; Giuseppe Giudice; Rosario Emanuele Perrotta
Journal:  F1000Res       Date:  2018-09-03

Review 9.  Global Aesthetics Consensus: Avoidance and Management of Complications from Hyaluronic Acid Fillers-Evidence- and Opinion-Based Review and Consensus Recommendations.

Authors:  Massimo Signorini; Steven Liew; Hema Sundaram; Koenraad L De Boulle; Greg J Goodman; Gary Monheit; Yan Wu; Ada R Trindade de Almeida; Arthur Swift; André Vieira Braz
Journal:  Plast Reconstr Surg       Date:  2016-06       Impact factor: 4.730

10.  Managing intravascular complications following treatment with calcium hydroxylapatite: An expert consensus.

Authors:  Jani van Loghem; David Funt; Tatjana Pavicic; Kate Goldie; Yana Yutskovskaya; Sabrina Fabi; Pieter Siebenga; Job Thuis; Joseph Hkeik; Jonathan Kadouch; Welf Prager; Nabila Azib; Gabriela Casabona; Steve Dayan; Shino Bay Aguilera; Philippe Snozzi; Peerooz Saeed
Journal:  J Cosmet Dermatol       Date:  2020-03-17       Impact factor: 2.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.